Lupus (SLE): Symptoms, Diagnosis and All Treatment Options Explained

Introduction of Lupus SLE

Systemic lupus erythematosus — universally known as lupus or SLE — is one of the most complex autoimmune diseases in medicine. It can affect virtually every organ in the body, its symptoms mimic dozens of other conditions, and it follows an unpredictable pattern of flares and remissions that makes it challenging to diagnose and manage.

Approximately 1.5 million Americans live with lupus, with women — particularly those of African American, Hispanic, Asian, and Native American descent — affected at significantly higher rates than men. Most diagnoses occur between the ages of 15 and 45.

Despite its complexity, the majority of people with lupus today are able to live full, active lives with the right treatment. Advances in understanding the disease and in treatment options — particularly the universal use of Hydroxychloroquine as a cornerstone of management — have transformed outcomes significantly.

This complete guide covers what lupus is, how to recognise it, how it is diagnosed, and every major treatment option available.

What is Lupus?

Lupus is a chronic systemic autoimmune disease in which the immune system loses its ability to distinguish between foreign invaders (viruses, bacteria) and the body's own healthy tissue. The immune system generates antibodies — particularly antinuclear antibodies (ANA) and anti-double-stranded DNA (anti-dsDNA) — that attack the body's own cells and organs.

Unlike rheumatoid arthritis, which primarily targets joints, lupus is truly systemic — it can attack the skin, joints, kidneys, brain, heart, lungs, and blood simultaneously, or in different combinations in different patients.

Lupus follows a characteristic pattern:

• Flares

  periods of active disease when symptoms worsen

• Remissions

  periods when symptoms improve or disappear entirely

No two people with lupus have exactly the same disease — it is one of the most individually variable conditions in medicine, which is part of why it takes an average of 6 years from first symptoms to diagnosis in the USA.

Types of Lupus

Systemic Lupus Erythematosus (SLE)

The most common and most serious form. Can affect any organ system. This guide focuses primarily on SLE.

Cutaneous (Discoid) Lupus Erythematosus (DLE)

Affects primarily the skin — causing chronic scarring rashes, most commonly on the face, scalp, and ears. Does not typically cause systemic organ involvement. Approximately 10% of people with DLE develop SLE.

Drug-Induced Lupus

Some medicines (including hydralazine, procainamide, isoniazid) can trigger a lupus-like condition that typically resolves when the medicine is stopped.

Neonatal Lupus

A rare condition affecting newborns of mothers with specific lupus antibodies. Usually resolves within months.

Symptoms of Lupus

Lupus symptoms vary widely between individuals and over time. The most common manifestations include:

Constitutional symptoms:

• Persistent fatigue — one of the most debilitating and common symptoms, often disproportionate to objective disease activity

• Fever without infection

• Unexplained weight loss

Skin and hair:

• Butterfly (malar) rash — a characteristic rash across the cheeks and bridge of the nose resembling butterfly wings, present in approximately 50% of lupus patients

• Photosensitivity — skin rashes triggered or worsened by sun exposure

• Discoid rashes — raised, scaly patches that can scar

• Mouth ulcers

• Hair loss (alopecia)

Joints:

• Joint pain, swelling, and morning stiffness — typically in the small joints of the hands and wrists, similar to RA but usually without the erosive joint damage

• Arthralgia (joint pain without visible swelling) is extremely common

Kidneys (lupus nephritis):

• Present in approximately 50% of lupus patients

• Can cause protein and blood in the urine, high blood pressure, swelling of the legs

• The most common cause of serious long-term complications in lupus

• Often has no obvious symptoms until significantly advanced — regular urine testing is essential

Nervous system:

• Headaches, brain fog, and cognitive difficulties ("lupus fog")

• Seizures

• Stroke — risk is elevated in lupus, particularly in patients with antiphospholipid syndrome

Cardiovascular:

• Pericarditis (inflammation of the heart lining)

• Accelerated atherosclerosis — cardiovascular disease is the leading cause of long-term mortality in lupus

• Antiphospholipid syndrome — increased blood clotting risk, miscarriage risk

  
  

Blood:

• Anaemia — very common

• Thrombocytopenia (low platelets)

• Lymphopenia (low lymphocytes)

Lungs:

• Pleuritis (inflammation of the lung lining) — causes sharp chest pain worsened by breathing

• Interstitial lung disease

How is Lupus Diagnosed?

Lupus is one of the most challenging diagnoses in medicine because its symptoms overlap with dozens of other conditions. Diagnosis requires a combination of clinical features, laboratory results, and exclusion of other causes.

Blood tests:

• -ANA (antinuclear antibody)

  positive in over 95% of lupus patients. However, ANA can be positive in many other conditions — it is a screening test, not a diagnostic test

• Anti-dsDNA antibody

  more specific for lupus; levels fluctuate with disease activity

• Anti-Sm antibody

  highly specific for lupus

• Anti-Ro/SSA and anti-La/SSB

  associated with cutaneous lupus and neonatal lupus risk

• Antiphospholipid antibodies

  associated with clotting and pregnancy loss

• Complement levels (C3, C4)

  tend to fall during active lupus

• Full blood count

  anaemia, low white cells, low platelets

• Renal function + urinalysis

  essential for detecting lupus nephritis

Classification criteria:

The 2019 ACR/EULAR classification criteria are used to standardise lupus diagnosis. They award points across seven domains — constitutional symptoms, skin, joints, neurological, serosal (heart/lung linings), blood, and immunological tests. A score of 10 points or more in a patient with a positive ANA meets classification criteria for SLE.

Treatment Options for Lupus

The goals of lupus treatment are:

• Prevent and manage flares

• Protect organs from damage — particularly kidneys, heart, and brain

• Minimise treatment side effects

• Maintain the best possible quality of life

1. Hydroxychloroquine (HCQ / HCQS) — The Cornerstone

Hydroxychloroquine is prescribed to virtually every lupus patient and continued for life — unless clearly contraindicated. This is not an overstatement. Multiple large studies have demonstrated that Hydroxychloroquine:

• Reduces the frequency and severity of lupus flares by 50%

• Reduces the risk of organ damage accumulation over time

• Significantly reduces cardiovascular events — particularly relevant given lupus patients' elevated cardiovascular risk

• Reduces the risk of developing lupus nephritis

• Reduces blood clotting risk in patients with antiphospholipid antibodies

• Improves long-term survival

• Is safe during pregnancy — one of the very few lupus medicines that can be continued throughout pregnancy

Dose: typically 200–400mg per day (not exceeding 5mg/kg/day based on body weight to minimise retinal toxicity). Annual eye checks recommended after 5 years.

At TheMedicineKart, we stock generic [HCQS Hydroxychloroquine tablets] and [USA-to-USA version] at significant savings off branded Plaquenil. For detailed HCQS information, see our complete [Hydroxychloroquine Guide].

2. NSAIDs (Non-Steroidal Anti-Inflammatory Drugs)

For joint pain, mild serositis (pleuritis/pericarditis), and fever during flares. Ibuprofen and naproxen are most commonly used. Should be avoided or used cautiously in patients with kidney involvement (lupus nephritis) due to their effect on renal blood flow.

3. Corticosteroids (Prednisolone)

The most powerful tool for rapidly controlling active flares — particularly major organ involvement such as lupus nephritis, neurological lupus, or severe haematological manifestations. However, they carry significant long-term side effects (bone thinning, diabetes, cardiovascular risk, weight gain) and the goal of modern lupus management is to use the lowest effective corticosteroid dose for the shortest possible time.

4. Conventional Immunosuppressants

For organ-threatening lupus or disease not adequately controlled with Hydroxychloroquine and corticosteroids:

• Azathioprine (Imuran)

  widely used maintenance immunosuppressant for lupus nephritis and systemic disease; safe in pregnancy

• Mycophenolate mofetil (CellCept)

  now the preferred agent for induction and maintenance of lupus nephritis; more effective than cyclophosphamide with fewer side effects in most patients; not safe in pregnancy

• Cyclophosphamide

  reserved for severe organ-threatening lupus, particularly proliferative nephritis and CNS lupus

• Methotrexate

  useful for skin and joint manifestations; not safe in pregnancy

5. Biological Medicines

• Belimumab (Benlysta)

  the first biologic specifically approved for lupus (2011). Targets BLyS, a protein that promotes B-cell survival and antibody production. Given as monthly intravenous infusion or weekly subcutaneous injection. Reduces flare rates and protects kidney function.

• Anifrolumab (Saphnelo)

  approved in 2021, targets the type I interferon receptor. Reduces skin and joint disease activity.

• Rituximab

  used off-label for severe refractory lupus, particularly haematological manifestations

6. Managing Specific Complications

• Lupus nephritis

  early aggressive treatment with mycophenolate + hydroxychloroquine + short-course corticosteroids, with belimumab increasingly used

• Antiphospholipid syndrome

  long-term anticoagulation (warfarin or low-molecular-weight heparin) to prevent clotting events

• Cardiovascular risk reduction

• statins, blood pressure control, smoking cessation

7. Lifestyle Measures

• Sun protection

  SPF 50+ sunscreen daily, protective clothing, avoiding midday sun (photosensitivity is a major flare trigger)

• Smoking cessation

  smoking worsens lupus disease activity and cardiovascular risk

• Vaccination

  lupus patients are immunocompromised and should receive all recommended vaccinations (avoiding live vaccines when on immunosuppressants)

• Regular monitoring

  blood tests, urine protein, blood pressure, eye checks (for HCQ), bone density (if on corticosteroids)

Living with Lupus: Key Facts

• Lupus is not contagious

• Lupus cannot currently be cured, but the majority of patients achieve good disease control with appropriate treatment

• Pregnancy with lupus requires careful specialist management — ideally planned during a period of low disease activity, with Hydroxychloroquine continued throughout

• Emotional and psychological support — depression and anxiety are significantly more common in lupus patients; addressing mental health is a core part of comprehensive lupus care

Frequently Asked Questions

What is the butterfly rash in lupus?

The butterfly or malar rash is a characteristic skin manifestation of lupus — a reddish rash across both cheeks and the bridge of the nose in a pattern resembling butterfly wings. It is present in approximately 50 percent of lupus patients and is often triggered or worsened by sun exposure. While distinctive, its absence does not rule out lupus.

Is hydroxychloroquine taken for life in lupus?

Yes. Hydroxychloroquine is considered a lifelong treatment for the vast majority of lupus patients because it reduces flare frequency, prevents organ damage, and reduces cardiovascular and clotting risk. Stopping it is associated with increased flare risk even in patients who are in remission. Decisions about reducing or stopping HCQ are made only by rheumatologists in carefully selected cases.

Can lupus affect pregnancy?

Yes. Lupus can increase the risk of pregnancy complications including miscarriage, preterm birth, and pre-eclampsia — particularly in patients with active disease, lupus nephritis, or antiphospholipid syndrome. With careful planning, good disease control, and specialist management, many lupus patients have successful pregnancies. Hydroxychloroquine is typically continued during pregnancy as it reduces the risk of flares.

How is lupus different from rheumatoid arthritis?

Both are autoimmune diseases, but lupus is systemic — it can affect multiple organs including kidneys, brain, and heart — while RA primarily affects joints. Lupus can also cause the characteristic butterfly rash, photosensitivity, and serious organ complications not seen in RA. Both conditions may be treated with Hydroxychloroquine, but RA typically requires additional DMARDs such as Methotrexate as a cornerstone.

What triggers a lupus flare?

Common flare triggers include sun exposure, infections, physical or emotional stress, certain medications, hormonal changes (including during menstrual cycles and after childbirth), and stopping Hydroxychloroquine. Identifying personal triggers through a symptom diary can help patients manage their condition proactively.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Lupus is a complex autoimmune condition requiring diagnosis and management by a qualified rheumatologist. Always consult a licensed healthcare professional before starting, changing, or stopping any medication.